NovoLog® Mix 70/30 FlexPen® Insulin Aspart Protamine / Insulin Aspart 70 U - 30 U / mL Injection 3 mL

Features

• NovoLog Mix 70/30 is indicated for the treatment of patients with diabetes mellitus for the control of hyperglycemia
• NovoLog Mix 70/30 is a blood glucose lowering agent with a rapid onset and an intermediate duration of action
• NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) is a human insulin analog suspension containing 70% insulin aspart protamine crystals and 30% soluble insulin aspart
• Presentation contains 100 Units of insulin aspart per mL (U-100)